On December 1st, the final conference of HAPPY PATIENT took place in Barcelona, bringing together nearly 50 people, including project partners and professionals from the academic, health, and research fields. It served as a gathering point to address the public health issue of antibiotic resistance on a European and global...
News
FeaturedHAPPY PATIENT has improved the correct use of antibiotics curbing antimicrobial resistance in Europe
In Europe, nearly 35,000 people die each year due to antimicrobial resistance, mainly caused by inappropriate antibiotic use, as reflected in data from the European Centre for Disease Prevention and Control. This is a global public health problem, which the World Health Organization (WHO) has already identified as one of...
FeaturedParticipation of the HAPPY PATIENT team in World Antibiotic Awareness Week
The HAPPY PATIENT team is joining World Antibiotic Awareness Week. Specifically, Maarten Lambert and Katja Taxis have been invited to an event organized by the International Pharmaceutical Federation (FIP). This Monday, Lambert was one of five panelists presenting some results of the HAPPY PATIENT project in a webinar with around...
FeaturedCarl Llor: «One of the successes of HAPPY PATIENT has been its powerful coordinating team and the good understanding among all partners»
The coordinator of HAPPY PATIENT, Dr. Carl Llor, researcher at IDIAP Jordi Gol and family doctor, explains in this interview his role in the project and everything that working on it for three years alongside professionals from around Europe has brought to him. HAPPY PATIENT emerges as a standout initiative...
FeaturedHAPPY PATIENT supports European Antibiotic Awareness Day
In Europe, around 35,000 individuals die annually to antimicrobial resistance, primarily stemming from the inappropriate use of antibiotics. This poses a public health dilemma necessitating immediate actions to safeguard the well-being of the population. In this context, HAPPY PATIENT has played a role in enhancing the correct prescription and dispensation...
FeaturedClosing of HAPPY PATIENT project with a final conference in Barcelona: don’t miss it!
For the past 3 years, HAPPY PATIENT has been working intensely to reduce the inappropriate use of antibiotics in four clinical settings (primary care, out-of-hours services, nursing homes and community pharmacies) by implementing interventions for healthcare professionals in 5 european countries (France, Greece, Lithuania, Poland and Spain). Now, HAPPY PATIENT...
FeaturedThe partners of the HAPPY PATIENT project analyze the project’s outcomes in Copenhagen
On June 8th and 9th, the partners of the HAPPY PATIENT project gathered in Copenhagen to assess the progress of this project, which started in 2021 and will run until the end of this year, 2023. Around thirty professionals from different parts of Europe gathered at the University of Copenhagen...
FeaturedProfessor Lars Bjerrum highlights the role of the IDIAPJGol in European research projects
Last week, the Research Institute in Primary Healthcare IDIAPJGol and the Catalan Institute of Health (ICS) presented their Annual Awards for "Research in Primary Health Care IDIAPJGol-ICS". A total of 23 researchers were awarded in different categories.
FeaturedEuropean Commission proposes a unified market for medicines and incentives for antibiotic development to address drug shortages in EU
The European Commission has recently put forth a proposal to amend the EU pharmaceutical legislation on April 26, 2023 (available at https://health.ec.europa.eu/system/files/2023-04/com_2023_193_1_act_en.pdf). This proposed revision aims to establish a unified market for medicines across all EU member states, thereby promoting greater accessibility to novel and effective drugs while also tackling...
FeaturedWHO warns of too few new drugs for deadly superbugs
The WHO has called on governments and pharmaceutical companies to invest in research and development of new antibiotics and has also recommended that antibiotics be used more judiciously to prevent the emergence of drug-resistant bacteria.
FeaturedSpain becomes a benchmark in Europe in the fight against antimicrobial resistance thanks to PROA certification standard
Global increase in antimicrobial resistance and complexity of infectious disease make it essential to establish Antimicrobial Use Optimization Programs (PROA) in the community and hospital areas. These programs have the objective of optimizing prescription of antibiotics, guaranteeing optimal clinical results, minimizing adverse effects derived from their use, controlling the appearance...
FeaturedResults, interventions, and qualitative studies debates at the second HAPPY PATIENT face-to-face meeting
Organized by the consortium partner, Universidad de las Palmas de Gran Canaria, and its Fundación Parque Tecnológico, the meeting highlighted the work done in recent months and designed the strategies for the final section of the project. The afternoon of the first day of the meeting, January 26, 2023, was...
FeaturedMore than 400 European experts
participate in the project HAPPY PATIENT
to optimize the use of antibiotics
• One of the research lines of the HAPPY PATIENT European project is to develop a strategy to improve communication between professionals and patients. • As the celebration of the European Day for the Prudent Use of Antibiotics approaches on November 18, it is worth remembering that the adequacy of...